Prognostic impact on survival of an unsuccessful conventional cytogenetic study in patients with myelodysplastic syndromes (MDS)

被引:2
|
作者
Cervera, J. [1 ]
Sole, F.
Haase, D.
Luno, E.
Such, E.
Nomdedeu, B.
Costa, D.
Bernal, T.
Vallespi, T.
Bueno, J.
Pedro, C.
Mallo, M.
Ardanaz, M. T.
Calasanz, M. J.
del Canizo, C.
Hernandez-Rivas, J. M.
Schanz, J.
Steidl, C.
Hildebrandt, B.
Carbonell, F.
Orero, M.
Ramos, F.
Marco, V.
Tormo, M.
Gomez, V.
Andreu, R.
Xicoy, B.
Amigo, M. L.
Munoz, J. A.
Bonanad, S.
Arrizabalaga, B.
Senent, M. L.
Germing, U.
Sanz, G. F.
机构
[1] Univ Gottingen, D-3400 Gottingen, Germany
关键词
D O I
10.1016/S0145-2126(09)70110-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:S75 / S76
页数:2
相关论文
共 50 条
  • [1] Novel cytogenetic markers with prognostic relevance in myelodysplastic syndromes (MDS): A study on 491 patients
    Bernasconi, P.
    Mersy, C.
    Boni, M.
    Cavigliano, P. M.
    Calatroni, S.
    Giardini, I
    Rocca, B.
    Zappatore, R.
    Caresana, M.
    Dambruoso, I
    Astori, C.
    Lazzarino, M.
    Bernasconi, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 37 - 37
  • [2] CYTOGENETIC STUDIES IN 69 PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    WEH, HJ
    CALAVREZOS, A
    SEEGER, D
    KUSE, R
    HOSSFELD, DK
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1987, 38 (02) : 166 - 172
  • [3] Has cytogenetic evolution any prognostic relevance in myelodysplastic syndromes (MDS)? A study on 153 patients.
    Bernasconi, Paolo
    Klersy, Catherine
    Boni, Marina
    Cavigliano, Paola Maria
    Calatroni, Silvia
    Giardini, Ilaria
    Rocca, Barbara
    Zappatore, Rita
    Dambruoso, Irene
    Caresana, Marilena
    Lazzarino, Mario
    BLOOD, 2007, 110 (11) : 725A - 726A
  • [4] CYTOGENETIC EVOLUTION AND CLONAL COMPOSITION: PROGNOSTIC IMPACT IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA FOLLOWING MDS
    Cevik, N.
    Haase, D.
    Schanz, J.
    HAEMATOLOGICA, 2014, 99 : 262 - 262
  • [5] Cytogenetic changes in myelodysplastic syndromes (MDS)
    Haus, O
    Kotlarek-Haus, S
    Czarnecka, M
    Potoczek, S
    Kyrcz-Krzemien, S
    Duszenko, E
    Makowska, I
    CYTOGENETICS AND CELL GENETICS, 1999, 85 (1-2): : 71 - 71
  • [6] Single Nucleotide Polymorphism Array Karyotyping: A Diagnostic and Prognostic Tool in Myelodysplastic Syndromes with Unsuccessful Conventional Cytogenetic Testing
    Arenillas, Leonor
    Mallo, Mar
    Ramos, Fernando
    Guinta, Kathryn
    Barragan, Eva
    Lumbreras, Eva
    Larrayoz, Maria-Jose
    De Paz, Raquel
    Tormo, Mar
    Abaigar, Maria
    Pedro, Carme
    Cervera, Jose
    Such, Esperanza
    Jose Calasanz, Maria
    Diez-Campelo, Maria
    Sanz, Guillermo F.
    Maria Hernandez, Jesus
    Luno, Elisa
    Saumell, Silvia
    Maciejewski, Jaroslaw
    Florensa, Lourdes
    Sole, Francesc
    GENES CHROMOSOMES & CANCER, 2013, 52 (12): : 1167 - 1177
  • [7] Impact of complete cytogenetic response on survival in patients with myelodysplastic syndromes.
    Urrutia, Samuel
    Sasaki, Koji
    Kantarjian, Hagop M.
    Jabbour, Elias
    Chien, Kelly Sharon
    Hammond, Danielle
    Bueso-Ramos, Carlos E.
    Khoury, Joseph
    Patel, Keyur P.
    Montalban-Bravo, Guillermo
    Wei, Yue
    Colla, Simona
    Short, Nicholas James
    Daver, Naval Guastad
    Borthakur, Gautam
    Kadia, Tapan M.
    Pierce, Sherry
    Wierda, William G.
    Garcia-Manero, Guillermo
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Impact on survival of different treatments for myelodysplastic syndromes (MDS)
    Nachtkamp, Kathrin
    Kuendgen, Andrea
    Strupp, Corinna
    Giagounidis, Aristoteles
    Kobbe, Guido
    Gattermann, Norbert
    Haas, Rainer
    Germing, Ulrich
    LEUKEMIA RESEARCH, 2009, 33 (08) : 1024 - 1028
  • [9] Cytogenetic abnormalities at diagnosis are the most important prognostic factor in the myelodysplastic syndromes (MDS)
    Buckstein, R
    Crump, M
    Imrie, K
    Sutton, D
    Pantalony, D
    Sher, G
    Stewart, AK
    Keating, A
    BLOOD, 1996, 88 (10) : 2317 - 2317
  • [10] Prognostic impact of bone marrow fibrosis in myelodysplastic syndromes (MDS)
    Baghikar, S.
    Braunstein, S.
    Reinecke, P.
    Knipp, S.
    Haas, R.
    Hildebrandt, B.
    Gattermann, N.
    Germing, U.
    Schmidt-Graef, A.
    LEUKEMIA RESEARCH, 2007, 31 : S100 - S100